Literature DB >> 1148773

Maturity onset diabetes mellitus: response to intensive dietary management.

D R Hadden, D A Montgomery, R J Skelly, E R Trimble, J A Weaver, E A Wilson, K D Buchanan.   

Abstract

Analysis of the first six months of intensive dietary management of 57 maturity onset diabetics showed that a large proportion of such patients could be satisfactorily controlled without the need of either oral hypoglycaemic agents or insulin. A dietitian's assessment of the patient's adherence to the prescribed diet allowed groups of good and poor dieters to be selected. Among the poor dieters the plasma insulin and triglyceride levels were significantly increased though plasma glucose levels were not significantly higher. Dietary adherence may thus be an prognostic risk factor in this group of diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1148773      PMCID: PMC1674182          DOI: 10.1136/bmj.3.5978.276

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  The difference between the glucose concentrations in plasma and whole blood.

Authors:  H C Holtkamp; N J Verhoef; B Leijnse
Journal:  Clin Chim Acta       Date:  1975-02-22       Impact factor: 3.786

2.  Coronary care for myocardial infarction in diabetics.

Authors:  N G Soler; B L Pentecost; M A Bennett; M G FitzGerald; P Lamb; J M Malins
Journal:  Lancet       Date:  1974-03-23       Impact factor: 79.321

3.  Myocardial infarction in maturity-onset diabetics. A retrospective study.

Authors:  D R Hadden; D A Montgomery; J A Weaver
Journal:  Lancet       Date:  1972-02-12       Impact factor: 79.321

4.  Ischaemic heart-disease in diabetics. A prospective study.

Authors:  D Boyle; D R Hadden; S K Bhatia; D A Montgomery; J A Weaver
Journal:  Lancet       Date:  1972-02-12       Impact factor: 79.321

5.  Plasma or whole blood glucose?

Authors:  B Morrison; A Fleck
Journal:  Clin Chim Acta       Date:  1973-05-18       Impact factor: 3.786

6.  Plasma lipoproteins in adult diabetes.

Authors:  T M Hayes
Journal:  Clin Endocrinol (Oxf)       Date:  1972-07       Impact factor: 3.478

7.  Risk factors for myocardial infarction in maturity-onset diabetes mellitus.

Authors:  D R Hadden; D Boyle; D A Montgomery; J A Weaver
Journal:  Practitioner       Date:  1973-05

8.  Plasma triglyceride transport kinetics in diabetes mellitus.

Authors:  E A Nikkilä; M Kekki
Journal:  Metabolism       Date:  1973-01       Impact factor: 8.694

9.  Effect of carbohydrate restriction in obese diabetics: relationship of control to weight loss.

Authors:  J R Wall; D A Pyke; W G Oakley
Journal:  Br Med J       Date:  1973-03-10
  9 in total
  15 in total

1.  Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.

Authors:  György Paragh; Ildikó Seres; Mariann Harangi; Annamária Erdei; Mária Audikovszky; Lóránd Debreczeni; Anna Kovácsay; László Illyés; Gyula Pados
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

Review 2.  A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.

Authors:  Adrian Bagust; Marc Evans; Sophie Beale; Philip D Home; Andrew S Perry; Murray Stewart
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  D M Nathan; J B Buse; M B Davidson; R J Heine; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2006-08       Impact factor: 10.122

4.  The gut as an endocrine organ.

Authors:  K D Buchanan
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

Review 5.  The expanding clinical use of C-peptide radioimmunoassay.

Authors:  M Rendell
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

6.  Gliclazide: the effects on lipids in type II diabetes.

Authors:  M Delargy; M McGovern; A Johnson; G H Tomkin
Journal:  Ir J Med Sci       Date:  1985-03       Impact factor: 1.568

Review 7.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

8.  The effects of energy and carbohydrate restriction in patients with chronic diabetes mellitus.

Authors:  J R Perkins; T E West; P H Sönksen; C Lowy; C Iles
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

9.  The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with Type 2 (non-insulin-dependent) diabetes mellitus: a prospective study.

Authors:  L Kennedy; K Walshe; D R Hadden; J A Weaver; K D Buchanan
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

10.  Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-10-22       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.